The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 04, 2011
Filed:
Feb. 08, 2008
Akella Satya Surya Visweswara Srinivas, Chennai, IN;
Ravikumar Tadiparthi, Chennai, IN;
Ganapavarapu Veera Raghava Sharma, Chennai, IN;
Sappanimuthu Thirunavukkarasu, Chennai, IN;
Durairaj Peter Bhakiaraj, Chennai, IN;
Virendra Kachhadia, Chennai, IN;
Kilambi Narsimhan, Chennai, IN;
Sathya Narayana Thara, Chennai, IN;
Sriram Rajagopal, Chennai, IN;
Gaddam OM Reddy, Chennai, IN;
Sukunath Narayanan, Chennai, IN;
Venkatesan Parameswaran, Chennai, IN;
Venkatesan Janarthanam, Chennai, IN;
Maruthikumar Narayanam, Chennai, IN;
Sathyanarayana Gadde, Chennai, IN;
Uma Ramachandran, Chennai, IN;
Akella Satya Surya Visweswara Srinivas, Chennai, IN;
Ravikumar Tadiparthi, Chennai, IN;
Ganapavarapu Veera Raghava Sharma, Chennai, IN;
Sappanimuthu Thirunavukkarasu, Chennai, IN;
Durairaj Peter Bhakiaraj, Chennai, IN;
Virendra Kachhadia, Chennai, IN;
Kilambi Narsimhan, Chennai, IN;
Sathya Narayana Thara, Chennai, IN;
Sriram Rajagopal, Chennai, IN;
Gaddam Om Reddy, Chennai, IN;
Sukunath Narayanan, Chennai, IN;
Venkatesan Parameswaran, Chennai, IN;
Venkatesan Janarthanam, Chennai, IN;
Maruthikumar Narayanam, Chennai, IN;
Sathyanarayana Gadde, Chennai, IN;
Uma Ramachandran, Chennai, IN;
Orchid Research Laboratories Limited, Tamilnadu, IN;
Abstract
Novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof are described. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell-damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors, and useful for treating PDE4 mediated diseases.